Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


Articles published in Neurobiol Aging

Retrieve available abstracts of 342 articles:
HTML format



Single Articles


    January 2025
  1. TAKAHASHI MKN, Paradela RS, Grinberg LT, Leite REP, et al
    Hypertension may associate with cerebral small vessel disease and infarcts through the pathway of intracranial atherosclerosis.
    Neurobiol Aging. 2025;145:84-95.
    PubMed     Abstract available


  2. CHEN X, Juarez A, Mason S, Kobayashi S, et al
    Longitudinal relationships between Abeta and tau to executive function and memory in cognitively normal older adults.
    Neurobiol Aging. 2025;145:32-41.
    PubMed     Abstract available


    December 2024
  3. PIEVANI M, Ribaldi F, Toussas K, Da Costa S, et al
    Resting-state functional connectivity abnormalities in subjective cognitive decline: A 7T MRI study.
    Neurobiol Aging. 2024;144:104-113.
    PubMed     Abstract available


  4. DENG F, Dounavi ME, Plini ERG, Ritchie K, et al
    Cardiovascular risk of dementia is associated with brain-behaviour changes in cognitively healthy, middle-aged individuals.
    Neurobiol Aging. 2024;144:78-92.
    PubMed     Abstract available


  5. ALSEGIANI AS, Shah ZA
    Age-dependent sex differences in cofilin1 pathway (LIMK1/SSH1) and its association with AD biomarkers after chronic systemic inflammation in mice.
    Neurobiol Aging. 2024;144:43-55.
    PubMed     Abstract available


  6. BAMFORD AR, Adams JN, Kim S, McMillan LC, et al
    The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults.
    Neurobiol Aging. 2024;144:12-18.
    PubMed     Abstract available


    November 2024
  7. DUTT S, Bachman SL, Dahl MJ, Li Y, et al
    Locus coeruleus MRI contrast, cerebral perfusion, and plasma Alzheimer's disease biomarkers in older adults.
    Neurobiol Aging. 2024;147:12-21.
    PubMed     Abstract available


  8. DENKINGER M, Baker S, Harrison TM, Chadwick T, et al
    Cross-sectional and longitudinal relationships among blood-brain barrier disruption, Alzheimer's disease biomarkers, and cognition in cognitively normal older adults.
    Neurobiol Aging. 2024;146:15-23.
    PubMed     Abstract available


  9. SORDO L, Ubele MF, Boaz KA, Mefford JL, et al
    Calcineurin/NFAT inhibitors maintain cognition in a preclinical prevention study in an aging canine model of Alzheimer disease.
    Neurobiol Aging. 2024;146:1-14.
    PubMed     Abstract available


  10. YE Z, Pan Y, McCoy RG, Bi C, et al
    Contrasting association pattern of plasma low-density lipoprotein with white matter integrity in APOE4 carriers versus non-carriers.
    Neurobiol Aging. 2024;143:41-52.
    PubMed     Abstract available


  11. BEER S, Elmenhorst D, Bischof GN, Ramirez A, et al
    Explainable artificial intelligence identifies an AQP4 polymorphism-based risk score associated with brain amyloid burden.
    Neurobiol Aging. 2024;143:19-29.
    PubMed     Abstract available


    October 2024
  12. LU W, Shue F, Kurti A, Jeevaratnam S, et al
    Amyloid pathology and cognitive impairment in hAbeta-KI and APP(SAA)-KI mouse models of Alzheimer's disease.
    Neurobiol Aging. 2024;145:13-23.
    PubMed     Abstract available


  13. DAVIES-JENKINS CW, Workman CI, Hupfeld KE, Zollner HJ, et al
    Multimodal investigation of neuropathology and neurometabolites in mild cognitive impairment and late-life depression with (11)C-PiB beta-amyloid PET and 7T magnetic resonance spectroscopy.
    Neurobiol Aging. 2024;142:27-40.
    PubMed     Abstract available


    September 2024
  14. MACEDO AC, Therriault J, Tissot C, Aumont E, et al
    Modeling the progression of neuropsychiatric symptoms in Alzheimer's disease with PET-based Braak staging.
    Neurobiol Aging. 2024;144:127-137.
    PubMed     Abstract available


  15. GAUTIER MK, Kelley CM, Lee SH, Mufson EJ, et al
    Maternal choline supplementation rescues early endosome pathology in basal forebrain cholinergic neurons in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
    Neurobiol Aging. 2024;144:30-42.
    PubMed     Abstract available


  16. JIMENEZ-BALADO J, Habeck C, Stern Y, Eich T, et al
    The relationship between cortical thickness and white matter hyperintensities in mid to late life.
    Neurobiol Aging. 2024;141:129-139.
    PubMed     Abstract available


  17. KARIM HT, Lee S, Gerlach A, Stinley M, et al
    Hippocampal subfield volume in older adults with and without mild cognitive impairment: Effects of worry and cognitive reappraisal.
    Neurobiol Aging. 2024;141:55-65.
    PubMed     Abstract available


    August 2024
  18. PEREZ-MILLAN A, Thirion B, Falgas N, Borrego-Ecija S, et al
    Beyond group classification: Probabilistic differential diagnosis of frontotemporal dementia and Alzheimer's disease with MRI and CSF biomarkers.
    Neurobiol Aging. 2024;144:1-11.
    PubMed     Abstract available


  19. QUARESIMA V, Pilotto A, Trasciatti C, Tolassi C, et al
    Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA.
    Neurobiol Aging. 2024;143:30-40.
    PubMed     Abstract available


  20. CAVALLARI M, Touroutoglou A, Katsumi Y, Fong TG, et al
    Relationship between cortical brain atrophy, delirium, and long-term cognitive decline in older surgical patients.
    Neurobiol Aging. 2024;140:130-139.
    PubMed     Abstract available


  21. LIBRI I, Silvestri C, Caratozzolo S, Alberici A, et al
    Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders.
    Neurobiol Aging. 2024;140:33-40.
    PubMed     Abstract available


    July 2024
  22. KAPOOR A, Dutt S, Alitin JPM, Sible IJ, et al
    Older adults with reduced cerebrovascular reactivity exhibit high white matter hyperintensity burden.
    Neurobiol Aging. 2024;139:5-10.
    PubMed     Abstract available


    June 2024
  23. DE AVILA C, Suazo C, Nolz J, Nicholas Cochran J, et al
    Reduced PIN1 expression in neocortical and limbic brain regions in female Alzheimer's patients correlates with cognitive and neuropathological phenotypes.
    Neurobiol Aging. 2024;141:160-170.
    PubMed     Abstract available


  24. CHATTERJEE A, Lee S, Diaz V, Saloner R, et al
    Associations of cerebrovascular disease and Alzheimer's disease pathology with cognitive decline: Analysis of the National Alzheimer's Coordinating Center Uniform Data Set.
    Neurobiol Aging. 2024;142:1-7.
    PubMed     Abstract available


  25. VAN AMERONGEN S, Das S, Kamps S, Goossens J, et al
    Cerebrospinal fluid biomarkers and cognitive trajectories in patients with Alzheimer's disease and a history of traumatic brain injury.
    Neurobiol Aging. 2024;141:121-128.
    PubMed     Abstract available


  26. BRANSBY L, Yassi N, Rosenich E, Buckley R, et al
    Associations between multidomain modifiable dementia risk factors with AD biomarkers and cognition in middle-aged and older adults.
    Neurobiol Aging. 2024;138:63-71.
    PubMed     Abstract available


  27. RODRIGUEZ-FERNANDEZ B, Sanchez-Benavides G, Genius P, Minguillon C, et al
    Association between telomere length and cognitive function among cognitively unimpaired individuals at risk of Alzheimer's disease.
    Neurobiol Aging. 2024;141:140-150.
    PubMed     Abstract available


    May 2024
  28. KNUDTZON SL, Nordengen K, Grontvedt GR, Jarholm J, et al
    Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer's disease.
    Neurobiol Aging. 2024;141:74-84.
    PubMed     Abstract available


  29. LIU R, Li JZ, Song JK, Zhou D, et al
    Corrigendum to: "Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits" [Neurobiol. Aging 35 (2014) 1275-1285].
    Neurobiol Aging. 2024 May 22:S0197-4580(24)00101.
    PubMed    


  30. YANG Q, Zhou X, Ma T
    Isoform-specific effects of neuronal inhibition of AMPK catalytic subunit on LTD impairments in a mouse model of Alzheimer's disease.
    Neurobiol Aging. 2024;140:116-121.
    PubMed     Abstract available


  31. BERNOCCHI F, Bonomi CG, Assogna M, Moreschini A, et al
    Astrocytic-derived vascular remodeling factors are independently associated with blood brain barrier permeability in Alzheimer's disease.
    Neurobiol Aging. 2024;141:66-73.
    PubMed     Abstract available


  32. LOPEZ S, Hampel H, Chiesa PA, Del Percio C, et al
    The association between posterior resting-state EEG alpha rhythms and functional MRI connectivity in older adults with subjective memory complaint.
    Neurobiol Aging. 2024;137:62-77.
    PubMed     Abstract available


  33. POOLE VN, Ridwan AR, Arfanakis K, Dawe RJ, et al
    Associations of brain morphology with cortical proteins of cognitive resilience.
    Neurobiol Aging. 2024;137:1-7.
    PubMed     Abstract available


    April 2024
  34. WINFREE RL, Erreger K, Phillips J, Seto M, et al
    Elevated protease-activated receptor 4 (PAR4) gene expression in Alzheimer's disease predicts cognitive decline.
    Neurobiol Aging. 2024;140:93-101.
    PubMed     Abstract available


  35. JANG I, Li B, Rashid B, Jacoby J, et al
    Brain structural indicators of beta-amyloid neuropathology.
    Neurobiol Aging. 2024;136:157-170.
    PubMed     Abstract available


  36. ROBINSON B, Bhamidi S, Dayan E
    The spatial distribution of coupling between tau and neurodegeneration in amyloid-beta positive mild cognitive impairment.
    Neurobiol Aging. 2024;136:70-77.
    PubMed     Abstract available


  37. WHITMAN ET, Ryan CP, Abraham WC, Addae A, et al
    A blood biomarker of the pace of aging is associated with brain structure: replication across three cohorts.
    Neurobiol Aging. 2024;136:23-33.
    PubMed     Abstract available


    March 2024
  38. NENCHA U, Rigoni I, Ribaldi F, Altomare D, et al
    Alterations in gamma frequency oscillations correlate with cortical tau deposition in Alzheimer's disease.
    Neurobiol Aging. 2024;139:1-4.
    PubMed     Abstract available


  39. ROYSE SK, Snitz BE, Hill AV, Reese AC, et al
    Apolipoprotein E and Alzheimer's disease pathology in African American older adults.
    Neurobiol Aging. 2024;139:11-19.
    PubMed     Abstract available


  40. SHAFIEE N, Fonov V, Dadar M, Spreng RN, et al
    Degeneration in Nucleus basalis of Meynert signals earliest stage of Alzheimer's disease progression.
    Neurobiol Aging. 2024;139:54-63.
    PubMed     Abstract available


  41. INAGAKI R, Yamakuni T, Saito T, Saido TC, et al
    Preventive effect of propolis on cognitive decline in Alzheimer's disease model mice.
    Neurobiol Aging. 2024;139:20-29.
    PubMed     Abstract available


  42. ALMEIDA FC, Jesus T, Coelho A, Quintas-Neves M, et al
    Psychosis in Alzheimer's disease is associated with specific changes in brain MRI volume, cognition and neuropathology.
    Neurobiol Aging. 2024;138:10-18.
    PubMed     Abstract available


  43. TAGHVAEI M, Mechanic-Hamilton DJ, Sadaghiani S, Shakibajahromi B, et al
    Impact of white matter hyperintensities on structural connectivity and cognition in cognitively intact ADNI participants.
    Neurobiol Aging. 2024;135:79-90.
    PubMed     Abstract available


  44. ZHANG YN, Chen XL, Guo LY, Jiang PR, et al
    Downregulation of peripheral luteinizing hormone rescues ovariectomy-associated cognitive deficits in APP/PS1 mice.
    Neurobiol Aging. 2024;135:60-69.
    PubMed     Abstract available


  45. HEMMINGHYTH MS, Chwiszczuk LJ, Breitve MH, Gisladottir B, et al
    Cerebrospinal fluid neurofilament light chain mediates age-associated lower learning and memory in healthy adults.
    Neurobiol Aging. 2024;135:39-47.
    PubMed     Abstract available


  46. BABILONI C, Noce G, Tucci F, Jakhar D, et al
    Poor reactivity of posterior electroencephalographic alpha rhythms during the eyes open condition in patients with dementia due to Parkinson's disease.
    Neurobiol Aging. 2024;135:1-14.
    PubMed     Abstract available


    February 2024
  47. YILDIRIM E, Akturk T, Hanoglu L, Yener G, et al
    Lower oddball event-related EEG delta and theta responses in patients with dementia due to Parkinson's and Lewy body than Alzheimer's disease.
    Neurobiol Aging. 2024;137:78-93.
    PubMed     Abstract available


  48. NAUDE J, Wang M, Leon R, Smith E, et al
    Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment.
    Neurobiol Aging. 2024;138:19-27.
    PubMed     Abstract available


  49. AI M, Morris TP, Noriega de la Colina A, Thovinakere N, et al
    Midlife physical activity engagement is associated with later-life brain health.
    Neurobiol Aging. 2024;134:146-159.
    PubMed     Abstract available


  50. BABILONI C, Jakhar D, Tucci F, Del Percio C, et al
    Resting state electroencephalographic alpha rhythms are sensitive to Alzheimer's disease mild cognitive impairment progression at a 6-month follow-up.
    Neurobiol Aging. 2024;137:19-37.
    PubMed     Abstract available


    January 2024
  51. LAN F, Roquet D, Dalton MA, El-Omar H, et al
    Exploring graded profiles of hippocampal atrophy along the anterior-posterior axis in semantic dementia and Alzheimer's disease.
    Neurobiol Aging. 2024;135:70-78.
    PubMed     Abstract available


  52. FERRARI-SOUZA JP, Brum WS, Hauschild LA, Da Ros LU, et al
    Vascular risk burden is a key player in the early progression of Alzheimer's disease.
    Neurobiol Aging. 2024;136:88-98.
    PubMed     Abstract available


  53. CIAMPA CJ, Morin TM, Murphy A, Joie R, et al
    DAT1 and BDNF polymorphisms interact to predict Abeta and tau pathology.
    Neurobiol Aging. 2024;133:115-124.
    PubMed     Abstract available


  54. HALE MR, Langhough R, Du L, Hermann BP, et al
    Associations between recall of proper names in story recall and CSF amyloid and tau in adults without cognitive impairment.
    Neurobiol Aging. 2024;133:87-98.
    PubMed     Abstract available


  55. SOOD A, Capuano AW, Wilson RS, Barnes LL, et al
    Metformin, age-related cognitive decline, and brain pathology.
    Neurobiol Aging. 2024;133:99-106.
    PubMed     Abstract available


  56. TWITTO-GREENBERG R, Liraz-Zaltsman S, Michaelson DM, Liraz O, et al
    9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models.
    Neurobiol Aging. 2024;133:16-27.
    PubMed     Abstract available


  57. SIMON SS, Varangis E, Lee S, Gu Y, et al
    In vivo tau is associated with change in memory and processing speed, but not reasoning, in cognitively unimpaired older adults.
    Neurobiol Aging. 2024;133:28-38.
    PubMed     Abstract available


    December 2023
  58. LEVIN F, Grothe MJ, Dyrba M, Franzmeier N, et al
    Longitudinal trajectories of cognitive reserve in hypometabolic subtypes of Alzheimer's disease.
    Neurobiol Aging. 2023;135:26-38.
    PubMed     Abstract available


  59. LAN G, Du J, Chen X, Wang Q, et al
    Association of APOE-epsilon4 and GAP-43-related presynaptic loss with beta-amyloid, tau, neurodegeneration, and cognitive decline.
    Neurobiol Aging. 2023;132:209-219.
    PubMed     Abstract available


  60. QIU T, Hong H, Zeng Q, Luo X, et al
    Degeneration of cholinergic white matter pathways and nucleus basalis of Meynert in individuals with objective subtle cognitive impairment.
    Neurobiol Aging. 2023;132:198-208.
    PubMed     Abstract available


  61. CATTERSON JH, Minkley L, Aspe S, Judd-Mole S, et al
    Protein retention in the endoplasmic reticulum rescues Abeta toxicity in Drosophila.
    Neurobiol Aging. 2023;132:154-174.
    PubMed     Abstract available


  62. KAN CN, Huang X, Zhang L, Hilal S, et al
    Comorbid amyloid with cerebrovascular disease in domain-specific cognitive and neuropsychiatric disturbances: a cross-sectional memory clinic study.
    Neurobiol Aging. 2023;132:47-55.
    PubMed     Abstract available


    November 2023
  63. CHIN KS, Holper S, Loveland P, Churilov L, et al
    Prevalence of cerebral microbleeds in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia: A systematic review and meta-analysis.
    Neurobiol Aging. 2023;134:74-83.
    PubMed     Abstract available


  64. LI JQ, Song JH, Suckling J, Wang YJ, et al
    Disease trajectories in older adults with non-AD pathologic change and comparison with Alzheimer's disease pathophysiology: A longitudinal study.
    Neurobiol Aging. 2023;134:106-114.
    PubMed     Abstract available


  65. ROCCATI E, Collins JM, Bindoff AD, Alty JE, et al
    Modifiable risk factors for dementia, cognition, and plasma phosphorylated tau 181 in a large-scale cohort of Australian older adults.
    Neurobiol Aging. 2023;131:106-114.
    PubMed     Abstract available


  66. GREGORY S, Blennow K, Ritchie CW, Shannon OM, et al
    Mediterranean diet is associated with lower white matter lesion volume in Mediterranean cities and lower cerebrospinal fluid Abeta(42) in non-Mediterranean cities in the EPAD LCS cohort.
    Neurobiol Aging. 2023;131:29-38.
    PubMed     Abstract available


  67. ZENUNI H, Bovenzi R, Bissacco J, Grillo P, et al
    Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease.
    Neurobiol Aging. 2023;131:24-28.
    PubMed     Abstract available


  68. AKSNES M, Capogna E, Vidal-Pineiro D, Chaudhry FA, et al
    Matrix metalloproteinases are associated with brain atrophy in cognitively unimpaired individuals.
    Neurobiol Aging. 2023;131:11-23.
    PubMed     Abstract available


    October 2023
  69. NUYTEMANS K, Rajabli F, Jean-Francois M, Kurup JT, et al
    Genetic analyses in multiplex families confirms chromosome 5q35 as a risk locus for Alzheimer's Disease in individuals of African Ancestry.
    Neurobiol Aging. 2023;133:125-133.
    PubMed     Abstract available


  70. KANG S, Jeon S, Lee YG, Ye BS, et al
    Dopamine transporter positron emission tomography in patients with Alzheimer's disease with Lewy body disease features.
    Neurobiol Aging. 2023;134:57-65.
    PubMed     Abstract available


  71. LEE BN, Wang J, Hall MA, Kim D, et al
    Sex modifies effects of imaging and CSF biomarkers on cognitive and functional outcomes: a study of Alzheimer's disease.
    Neurobiol Aging. 2023;133:67-77.
    PubMed     Abstract available


  72. LI J, Chen D, Liu H, Xi Y, et al
    Identifying potential genetic epistasis implicated in Alzheimer's disease via detection of SNP-SNP interaction on quantitative trait CSF Abeta(42).
    Neurobiol Aging. 2023;134:84-93.
    PubMed     Abstract available


  73. COUGHLAN G, DeSouza B, Zhukovsky P, Hornberger M, et al
    Spatial cognition is associated with levels of phosphorylated-tau and beta-amyloid in clinically normal older adults.
    Neurobiol Aging. 2023;130:124-134.
    PubMed     Abstract available


  74. BEJIA I, Labidi J, Warniez A, Bayot M, et al
    Multi-approach comparative study of EEG patterns associated with the most common forms of dementia.
    Neurobiol Aging. 2023;130:30-39.
    PubMed     Abstract available


  75. LIZIO R, Lopez S, Babiloni C, Del Percio C, et al
    Resting state EEG rhythms in different stages of chronic kidney disease with mild cognitive impairment.
    Neurobiol Aging. 2023;130:70-79.
    PubMed     Abstract available


    September 2023
  76. ZHU M, Gu H, Bai H, Li Y, et al
    Role and molecular regulatory mechanisms of Hippo signaling pathway in Caenorhabditis elegans and mammalian cell models of Alzheimer's disease.
    Neurobiol Aging. 2023;134:9-20.
    PubMed     Abstract available


  77. AERQIN Q, Chen XT, Ou YN, Ma YH, et al
    Associations between multimorbidity burden and Alzheimer's pathology in older adults without dementia: the CABLE study.
    Neurobiol Aging. 2023;134:1-8.
    PubMed     Abstract available


  78. ORCIANI C, Do Carmo S, Foret MK, Hall H, et al
    Early treatment with an M1 and sigma-1 receptor agonist prevents cognitive decline in a transgenic rat model displaying Alzheimer-like amyloid pathology.
    Neurobiol Aging. 2023;132:220-232.
    PubMed     Abstract available


  79. HONEA RA, Hunt S, Lepping RJ, Vidoni ED, et al
    Alzheimer's disease cortical morphological phenotypes are associated with TOMM40'523-APOE haplotypes.
    Neurobiol Aging. 2023;132:131-144.
    PubMed     Abstract available


  80. XIA Y, Maruff P, Dore V, Bourgeat P, et al
    Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's disease.
    Neurobiol Aging. 2023;132:120-130.
    PubMed     Abstract available


  81. LIM YY, Yassi N, Bransby L, Ayton S, et al
    CSF Abeta(42) and tau biomarkers in cognitively unimpaired Abeta- middle-aged and older APOE epsilon4 carriers.
    Neurobiol Aging. 2023;129:209-218.
    PubMed     Abstract available


  82. ALCHERA N, Garibotto V, Tomczyk S, Treyer V, et al
    Patterns of amyloid accumulation in amyloid-negative cases.
    Neurobiol Aging. 2023;129:99-108.
    PubMed     Abstract available


  83. NIKSERESHT G, Evia AM, Nag S, Leurgans SE, et al
    Neuropathologic correlates of cerebral microbleeds in community-based older adults.
    Neurobiol Aging. 2023;129:89-98.
    PubMed     Abstract available


  84. JONES KT, Gallen CL, Ostrand AE, Rojas JC, et al
    Gamma neuromodulation improves episodic memory and its associated network in amnestic mild cognitive impairment: a pilot study.
    Neurobiol Aging. 2023;129:72-88.
    PubMed     Abstract available


  85. RENNIE A, Ekman U, Wallert J, Muehlboeck JS, et al
    Comparing three neuropsychological subgrouping approaches in subjective and mild cognitive impairment from a naturalistic multicenter study.
    Neurobiol Aging. 2023;129:41-49.
    PubMed     Abstract available


    August 2023
  86. HOY KE, Emonson MRL, Bailey NW, Rogers C, et al
    Gamma connectivity predicts response to intermittent theta burst stimulation in Alzheimer's disease: a randomized controlled trial.
    Neurobiol Aging. 2023;132:13-23.
    PubMed     Abstract available


  87. TUBI MA, Wheeler K, Matsiyevskiy E, Hapenney M, et al
    White matter hyperintensity volume modifies the association between CSF vascular inflammatory biomarkers and regional FDG-PET along the Alzheimer's disease continuum.
    Neurobiol Aging. 2023;132:1-12.
    PubMed     Abstract available


  88. MOALLEMIAN S, Salmon E, Bahri MA, Beliy N, et al
    Multimodal imaging of microstructural cerebral alterations and loss of synaptic density in Alzheimer's disease.
    Neurobiol Aging. 2023;132:24-35.
    PubMed     Abstract available


  89. TERRACCIANO A, Walker K, An Y, Luchetti M, et al
    The association between personality and plasma biomarkers of astrogliosis and neuronal injury.
    Neurobiol Aging. 2023;128:65-73.
    PubMed     Abstract available


  90. KAPOOR A, Gaubert A, Yew B, Jang JY, et al
    Enlarged perivascular spaces and plasma Abeta42/Abeta40 ratio in older adults without dementia.
    Neurobiol Aging. 2023;128:43-48.
    PubMed     Abstract available


    July 2023
  91. COLMANT L, Bierbrauer A, Bellaali Y, Kunz L, et al
    Dissociating effects of aging and genetic risk of sporadic Alzheimer's disease on path integration.
    Neurobiol Aging. 2023;131:170-181.
    PubMed     Abstract available


  92. GROECHEL RC, Tripodis Y, Alosco ML, Mez J, et al
    Biomarkers of Alzheimer's disease in Black and/or African American Alzheimer's Disease Neuroimaging Initiative (ADNI) participants.
    Neurobiol Aging. 2023;131:144-152.
    PubMed     Abstract available


  93. CUKIER HN, Duarte CL, Laverde-Paz MJ, Simon SA, et al
    An Alzheimer's disease risk variant in TTC3 modifies the actin cytoskeleton organization and the PI3K-Akt signaling pathway in iPSC-derived forebrain neurons.
    Neurobiol Aging. 2023;131:182-195.
    PubMed     Abstract available


  94. ISELLA V, Licciardo D, Rebecchi G, Ferri F, et al
    A cognitive marker for Alzheimer disease pathology in primary progressive aphasia? A validation study in the clinical setting.
    Neurobiol Aging. 2023;131:153-155.
    PubMed     Abstract available


  95. SU Z, Zhang G, Li X, Zhang H, et al
    Inverse correlation between Alzheimer's disease and cancer from the perspective of hypoxia.
    Neurobiol Aging. 2023;131:59-73.
    PubMed     Abstract available


  96. GROECHEL RC, Tripodis Y, Alosco ML, Mez J, et al
    Annualized changes in rate of amyloid deposition and neurodegeneration are greater in participants who become amyloid positive than those who remain amyloid negative.
    Neurobiol Aging. 2023;127:33-42.
    PubMed     Abstract available


    June 2023
  97. SWINFORD CG, Risacher SL, Vosmeier A, Deardorff R, et al
    Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer's disease.
    Neurobiol Aging. 2023;130:103-113.
    PubMed     Abstract available


  98. PAN F, Wang Y, Wang Y, Wang X, et al
    Sex and APOE genotype differences in amyloid deposition and cognitive performance along the Alzheimer's Continuum.
    Neurobiol Aging. 2023;130:84-92.
    PubMed     Abstract available


  99. FRICK A, Besson G, Salmon E, Delhaye E, et al
    Perirhinal cortex is associated with fine-grained discrimination of conceptually confusable objects in Alzheimer's disease.
    Neurobiol Aging. 2023;130:1-11.
    PubMed     Abstract available


  100. INAYAT S, McAllister BB, Chang H, Lacoursiere SG, et al
    Weak-hyperactive hippocampal CA1 neurons in the prodromal stage of Alzheimer's disease in hybrid App(NL-G-F/NL-G-F) x Thy1-GCaMP6s(+/-) mice suggest disrupted plasticity.
    Neurobiol Aging. 2023;130:154-171.
    PubMed     Abstract available


  101. HOPKINS WD, Li X, Roberts N, Mulholland MM, et al
    Age differences in cortical thickness and their association with cognition in chimpanzee (Pan troglodytes).
    Neurobiol Aging. 2023;126:91-102.
    PubMed     Abstract available


    May 2023
  102. FLORES-SANDOVAL AA, Davila-Perez P, Buss SS, Donohoe K, et al
    Spectral power ratio as a measure of EEG changes in mild cognitive impairment due to Alzheimer's disease: a case-control study.
    Neurobiol Aging. 2023;130:50-60.
    PubMed     Abstract available


  103. SUN Z, Zhao C, Liu X, Zhang P, et al
    Mutation analysis of the ECE1 gene in late-onset Alzheimer's disease.
    Neurobiol Aging. 2023;129:58-61.
    PubMed     Abstract available


  104. WILLIAMS ME, Elman JA, Bell TR, Dale AM, et al
    Higher cortical thickness/volume in Alzheimer's-related regions: protective factor or risk factor?
    Neurobiol Aging. 2023;129:185-194.
    PubMed     Abstract available


  105. MIKKELSEN JD, Kaad S, Aripaka SS, Finsen B, et al
    Synaptic vesicle glycoprotein 2A (SV2A) levels in the cerebral cortex in patients with Alzheimer's disease: a radioligand binding study in postmortem brains.
    Neurobiol Aging. 2023;129:50-57.
    PubMed     Abstract available


  106. WEIGAND AJ, Ortiz G, Walker KS, Galasko DR, et al
    APOE differentially moderates cerebrospinal fluid and plasma phosphorylated tau181 associations with multi-domain cognition.
    Neurobiol Aging. 2023;125:1-8.
    PubMed     Abstract available


    April 2023
  107. PAPADATOS Z, Phillips NA
    Olfactory function reflects episodic memory performance and atrophy in the medial temporal lobe in individuals at risk for Alzheimer's disease.
    Neurobiol Aging. 2023;128:33-42.
    PubMed     Abstract available


  108. SOTO PL, Young ME, DiMarco GM, George B, et al
    Longitudinal assessment of cognitive function in the APPswe/PS1dE9 mouse model of Alzheimer's-related beta-amyloidosis.
    Neurobiol Aging. 2023 Apr 2:S0197-4580(23)00062.
    PubMed     Abstract available


  109. LI YY, Yu KY, Cui YJ, Wang ZJ, et al
    Orexin-A aggravates cognitive deficits in 3xTg-AD mice by exacerbating synaptic plasticity impairment and affecting amyloid beta metabolism.
    Neurobiol Aging. 2023;124:71-84.
    PubMed     Abstract available


  110. QIAO J, Wang T, Shao Z, Zhu Y, et al
    Genetic correlation and gene-based pleiotropy analysis for four major neurodegenerative diseases with summary statistics.
    Neurobiol Aging. 2023;124:117-128.
    PubMed     Abstract available


  111. SUN H, Ye E, Paixao L, Ganglberger W, et al
    The sleep and wake electroencephalogram over the lifespan.
    Neurobiol Aging. 2023;124:60-70.
    PubMed     Abstract available


  112. TETLOW AM, Jackman BM, Alhadidy MM, Muskus P, et al
    Neural atrophy produced by AAV tau injections into hippocampus and anterior cortex of middle-aged mice.
    Neurobiol Aging. 2023;124:39-50.
    PubMed     Abstract available


  113. LIBBY JB, Seto M, Khan OA, Liu D, et al
    Whole blood transcript and protein abundance of the vascular endothelial growth factor family relate to cognitive performance.
    Neurobiol Aging. 2023;124:11-17.
    PubMed     Abstract available


    March 2023
  114. KASUGA K, Tsukie T, Kikuchi M, Tokutake T, et al
    The clinical application of optimized AT(N) classification in Alzheimer's clinical syndrome (ACS) and non-ACS conditions.
    Neurobiol Aging. 2023;127:23-32.
    PubMed     Abstract available


  115. WIGHTMAN DP, Savage JE, Tissink E, Romero C, et al
    The genetic overlap between Alzheimer's disease, amyotrophic lateral sclerosis, Lewy body dementia, and Parkinson's disease.
    Neurobiol Aging. 2023 Mar 12:S0197-4580(23)00050.
    PubMed     Abstract available


  116. NA H, Yang JB, Zhang Z, Gan Q, et al
    Peripheral apolipoprotein E proteins and their binding to LRP1 antagonize Alzheimer's disease pathogenesis in the brain during peripheral chronic inflammation.
    Neurobiol Aging. 2023;127:54-69.
    PubMed     Abstract available


  117. KESZYCKI R, Rodriguez G, Dunn JT, Locci A, et al
    Characterization of apathy-like behaviors in the 5xFAD mouse model of Alzheimer's disease.
    Neurobiol Aging. 2023;126:113-122.
    PubMed     Abstract available


  118. FLEEMAN RM, Snyder AM, Kuhn MK, Chan DC, et al
    Predictive link between systemic metabolism and cytokine signatures in the brain of apolipoprotein E epsilon4 mice.
    Neurobiol Aging. 2023;123:154-169.
    PubMed     Abstract available


    February 2023
  119. SUPIYEV A, Karlsson R, Wang Y, Koch E, et al
    Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging.
    Neurobiol Aging. 2023;126:103-112.
    PubMed     Abstract available


  120. MORRISON C, Dadar M, Manera AL, Collins DL, et al
    Racial differences in white matter hyperintensity burden in older adults.
    Neurobiol Aging. 2023;122:112-119.
    PubMed     Abstract available


  121. KIM BJ, Grossman M, Aleman TS, Song D, et al
    Retinal photoreceptor layer thickness has disease specificity and distinguishes predicted FTLD-Tau from biomarker-determined Alzheimer's disease.
    Neurobiol Aging. 2023;125:74-82.
    PubMed     Abstract available


  122. KELBERMAN MA, Rorabaugh JM, Anderson CR, Marriott A, et al
    Age-dependent dysregulation of locus coeruleus firing in a transgenic rat model of Alzheimer's disease.
    Neurobiol Aging. 2023;125:98-108.
    PubMed     Abstract available


    January 2023
  123. SETO M, Dumitrescu L, Mahoney ER, Sclafani AM, et al
    Multi-omic characterization of brain changes in the vascular endothelial growth factor family during aging and Alzheimer's disease.
    Neurobiol Aging. 2023;126:25-33.
    PubMed     Abstract available


  124. WANG C, Han X, Dong Y, Liu C, et al
    Associations of WWC1 variants with Alzheimer's disease and vascular dementia among rural older adults in China: A population-based study.
    Neurobiol Aging. 2023 Jan 8:S0197-4580(23)00003.
    PubMed     Abstract available


  125. WANG WE, Chen R, Mayrand RP, Adjouadi M, et al
    Association of longitudinal cognitive decline with diffusion MRI in Gray Matter, Amyloid, and Tau deposition.
    Neurobiol Aging. 2023;121:166-178.
    PubMed     Abstract available


  126. SONG H, Bharadwaj PK, Raichlen DA, Habeck CG, et al
    Association of homocysteine-related subcortical brain atrophy with white matter lesion volume and cognition in healthy aging.
    Neurobiol Aging. 2023;121:129-138.
    PubMed     Abstract available


  127. WANG X, Hu M, Xie Q, Geng C, et al
    Amyloid beta oligomers disrupt piriform cortical output via a serotonergic pathway.
    Neurobiol Aging. 2023;121:64-77.
    PubMed     Abstract available


  128. LLANO DA, Devanarayan P, Devanarayan V
    CSF peptides from VGF and other markers enhance prediction of MCI to AD progression using the ATN framework.
    Neurobiol Aging. 2023;121:15-27.
    PubMed     Abstract available


    December 2022
  129. ZHU M, Hou T, Jia L, Tan Q, et al
    Development and validation of a 13-gene signature associated with immune function for the detection of Alzheimer's disease.
    Neurobiol Aging. 2022;125:62-73.
    PubMed     Abstract available


  130. BAC B, Hicheri C, Weiss C, Buell A, et al
    The TgF344-AD rat: behavioral and proteomic changes associated with aging and protein expression in a transgenic rat model of Alzheimer's disease.
    Neurobiol Aging. 2022;123:98-110.
    PubMed     Abstract available


  131. HONDA K, Saito Y, Saito H, Toyoda M, et al
    Accumulation of amyloid-beta in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
    Neurobiol Aging. 2022;123:63-74.
    PubMed     Abstract available


  132. B SZABO A, Cattaud V, Bezzina C, Dard RF, et al
    Neuronal hyperexcitability in the Tg2576 mouse model of Alzheimer's disease - the influence of sleep and noradrenergic transmission.
    Neurobiol Aging. 2022;123:35-48.
    PubMed     Abstract available


  133. MADSEN LS, Parbo P, Ismail R, Gottrup H, et al
    Capillary dysfunction correlates with cortical amyloid load in early Alzheimer's disease.
    Neurobiol Aging. 2022;123:1-9.
    PubMed     Abstract available


  134. LI Z, Min S, Alliey-Rodriguez N, Giase G, et al
    Single-neuron whole genome sequencing identifies increased somatic mutation burden in Alzheimer's disease related genes.
    Neurobiol Aging. 2022 Dec 13:S0197-4580(22)00256.
    PubMed     Abstract available


  135. BUBAK AN, Merle L, Niemeyer CS, Baxter BD, et al
    Signatures for viral infection and inflammation in the proximal olfactory system in familial Alzheimer's disease.
    Neurobiol Aging. 2022;123:75-82.
    PubMed     Abstract available


  136. GUO Y, Yang YX, Zhang YR, Huang YY, et al
    Genome-wide association study of brain tau deposition as measured by (18)F-flortaucipir positron emission tomography imaging.
    Neurobiol Aging. 2022;120:128-136.
    PubMed     Abstract available


  137. PENG Z, Duggan MR, Dark HE, Daya GN, et al
    Association of liver disease with brain volume loss, cognitive decline, and plasma neurodegenerative disease biomarkers.
    Neurobiol Aging. 2022;120:34-42.
    PubMed     Abstract available


    November 2022
  138. FAN K, Francis L, Aslam MM, Bedison MA, et al
    Investigation of the independent role of a rare APOE variant (L28P; APOE*4Pittsburgh) in late-onset Alzheimer disease.
    Neurobiol Aging. 2022;122:107-111.
    PubMed     Abstract available


  139. AGHAKHANYAN G, Galgani A, Vergallo A, Lombardo F, et al
    Brain metabolic correlates of Locus Coeruleus degeneration in Alzheimer's disease: a multimodal neuroimaging study.
    Neurobiol Aging. 2022;122:12-21.
    PubMed     Abstract available


  140. LI X, Xu M, Bi R, Tan LW, et al
    Common and rare variants of EGF increase the genetic risk of Alzheimer's disease as revealed by targeted sequencing of growth factors in Han Chinese.
    Neurobiol Aging. 2022 Nov 3:S0197-4580(22)00223.
    PubMed     Abstract available


  141. FORREST SL, Wagner S, Kim A, Kovacs GG, et al
    Association of glial tau pathology and LATE-NC in the ageing brain.
    Neurobiol Aging. 2022;119:77-88.
    PubMed     Abstract available


  142. PHAM NTT, Graff-Radford J, Machulda MM, Spychalla AJ, et al
    Regional white matter hyperintensities in posterior cortical atrophy and logopenic progressive aphasia.
    Neurobiol Aging. 2022;119:46-55.
    PubMed     Abstract available


  143. GRIGOROVA M, Mak E, Brown SSG, Beresford-Webb J, et al
    Amyloid- beta and tau deposition influences cognitive and functional decline in Down syndrome.
    Neurobiol Aging. 2022;119:36-45.
    PubMed     Abstract available


  144. MAHON E, Lachman ME
    Voice biomarkers as indicators of cognitive changes in middle and later adulthood.
    Neurobiol Aging. 2022;119:22-35.
    PubMed     Abstract available


    October 2022
  145. ERSOEZLUE E, Rauchmann BS, Schneider-Axmann T, Wagner M, et al
    Lifelong experiences as a proxy of cognitive reserve moderate the association between connectivity and cognition in Alzheimer's disease.
    Neurobiol Aging. 2022;122:33-44.
    PubMed     Abstract available


  146. MIRABNAHRAZAM G, Ma D, Beaulac C, Lee S, et al
    Predicting time-to-conversion for dementia of Alzheimer's type using multi-modal deep survival analysis.
    Neurobiol Aging. 2022;121:139-156.
    PubMed     Abstract available


  147. WINFREE RL, Dumitrescu L, Blennow K, Zetterberg H, et al
    Biological correlates of elevated soluble TREM2 in cerebrospinal fluid.
    Neurobiol Aging. 2022;118:88-98.
    PubMed     Abstract available


  148. SETO M, Weiner RL, Dumitrescu L, Mahoney ER, et al
    RNASE6 is a novel modifier of APOE-epsilon4 effects on cognition.
    Neurobiol Aging. 2022;118:66-76.
    PubMed     Abstract available


  149. ZHUANG K, Chen X, Cassady KE, Baker SL, et al
    Metacognition, cortical thickness, and tauopathy in aging.
    Neurobiol Aging. 2022;118:44-54.
    PubMed     Abstract available


  150. CALCETAS AT, Thomas KR, Edmonds EC, Holmqvist SL, et al
    Increased regional white matter hyperintensity volume in objectively-defined subtle cognitive decline and mild cognitive impairment.
    Neurobiol Aging. 2022;118:1-8.
    PubMed     Abstract available


    September 2022
  151. WU W, Yu J, Qian X, Wang X, et al
    Intermediate-length CGG repeat expansion in NOTCH2NLC is associated with pathologically confirmed Alzheimer's disease.
    Neurobiol Aging. 2022 Sep 17. pii: S0197-4580(22)00203.
    PubMed     Abstract available


  152. SANLI BA, Whittaker KJ, Motsi GK, Shen E, et al
    Unbiased metabolome screen links serum urate to risk of Alzheimer's disease.
    Neurobiol Aging. 2022;120:167-176.
    PubMed     Abstract available


  153. COGSWELL PM, Wiste HJ, Mielke MM, Schwarz CG, et al
    CSF phosphorylated tau as an indicator of subsequent tau accumulation.
    Neurobiol Aging. 2022;117:189-200.
    PubMed     Abstract available


  154. LI H, Zhao J, Lai L, Xia Y, et al
    Loss of SST and PV positive interneurons in the ventral hippocampus results in anxiety-like behavior in 5xFAD mice.
    Neurobiol Aging. 2022;117:165-178.
    PubMed     Abstract available


  155. TAZWAR M, Evia AM, Tamhane AA, Ridwan AR, et al
    Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is associated with lower R2 relaxation rate: an ex-vivo MRI and pathology investigation.
    Neurobiol Aging. 2022;117:128-138.
    PubMed     Abstract available


  156. NUNES PV, Suemoto CK, Rodriguez RD, Paraizo Leite RE, et al
    Neuropathology of depression in non-demented older adults: A large postmortem study of 741 individuals.
    Neurobiol Aging. 2022;117:107-116.
    PubMed     Abstract available


  157. LAO PJ, Boehme AK, Morales C, Laing KK, et al
    Amyloid, cerebrovascular disease, and neurodegeneration biomarkers are associated with cognitive trajectories in a racially and ethnically diverse, community-based sample.
    Neurobiol Aging. 2022;117:83-96.
    PubMed     Abstract available


  158. YU X, Lophatananon A, Mekli K, Burns A, et al
    A suggested shared aetiology of dementia - a colocalization study.
    Neurobiol Aging. 2022;117:71-82.
    PubMed     Abstract available


    August 2022
  159. KOTLIAR K, Ortner M, Conradi A, Hacker P, et al
    Altered retinal cerebral vessel oscillation frequencies in Alzheimer's disease compatible with impaired amyloid clearance.
    Neurobiol Aging. 2022;120:117-127.
    PubMed     Abstract available


  160. PAULSEN AJ, Schubert CR, Pinto AA, Chappell RJ, et al
    Associations of sensory and motor function with blood-based biomarkers of neurodegeneration and Alzheimer's disease in midlife.
    Neurobiol Aging. 2022;120:177-188.
    PubMed     Abstract available


  161. CHANDLER H, Wise R, Linden D, Williams J, et al
    Alzheimer's genetic risk effects on cerebral blood flow across the lifespan are proximal to gene expression.
    Neurobiol Aging. 2022;120:1-9.
    PubMed     Abstract available


  162. VIDAL-PINEIRO D, Sorensen O, Blennow K, Capogna E, et al
    Relationship between cerebrospinal fluid neurodegeneration biomarkers and temporal brain atrophy in cognitively healthy older adults.
    Neurobiol Aging. 2022;116:80-91.
    PubMed     Abstract available


  163. SHEN B, Hernandez DG, Chitrala KN, Fanelli-Kuczmarski MT, et al
    APOE gene region methylation is associated with cognitive performance in middle-aged urban adults.
    Neurobiol Aging. 2022;116:41-48.
    PubMed     Abstract available


  164. MELIKYAN ZA, Corrada MM, Leiby AM, Sajjadi SA, et al
    Cognitive resilience to three dementia-related neuropathologies in an oldest-old man: A case report from The 90+ Study.
    Neurobiol Aging. 2022;116:12-15.
    PubMed     Abstract available


    July 2022
  165. THORP JG, Mitchell BL, Gerring ZF, Ong JS, et al
    Genetic evidence that the causal association of educational attainment with reduced risk of Alzheimer's disease is driven by intelligence.
    Neurobiol Aging. 2022 Jul 30. pii: S0197-4580(22)00164.
    PubMed     Abstract available


  166. BRACHER-SMITH M, Leonenko G, Baker E, Crawford K, et al
    Whole genome analysis in APOE4 homozygotes identifies the DAB1-RELN pathway in Alzheimer's disease pathogenesis.
    Neurobiol Aging. 2022;119:67-76.
    PubMed     Abstract available


  167. GRAFF-RADFORD J, Mielke MM, Hofrenning EI, Kouri N, et al
    Association of plasma biomarkers of amyloid and neurodegeneration with cerebrovascular disease and Alzheimer's disease.
    Neurobiol Aging. 2022;119:1-7.
    PubMed     Abstract available


  168. CORRIVEAU-LECAVALIER N, Decarie-Labbe L, Mellah S, Belleville S, et al
    Sex differences in patterns of associative memory-related activation in individuals at risk of Alzheimer's disease.
    Neurobiol Aging. 2022;119:89-101.
    PubMed     Abstract available


  169. MATHIOUDAKIS L, Dimovasili C, Bourbouli M, Latsoudis H, et al
    Study of Alzheimer's disease- and frontotemporal dementia-associated genes in the Cretan Aging Cohort.
    Neurobiol Aging. 2022 Jul 11. pii: S0197-4580(22)00146.
    PubMed     Abstract available


  170. SLEAT DE, Maita I, Banach-Petrosky W, Larrimore KE, et al
    Elevated levels of tripeptidyl peptidase 1 do not ameliorate pathogenesis in a mouse model of Alzheimer disease.
    Neurobiol Aging. 2022;118:106-107.
    PubMed     Abstract available


  171. JIANG L, Qin Y, Zhao YW, Zeng Q, et al
    PSEN1 G417S mutation in a Chinese pedigree causing early-onset parkinsonism with cognitive impairment.
    Neurobiol Aging. 2022;115:70-76.
    PubMed     Abstract available


  172. FULOPOVA B, Bennett W, Summers BS, Stuart KE, et al
    Cortical axon sub-population maintains density, but not turnover, of en passant boutons in the aged APP/PS1 amyloidosis model.
    Neurobiol Aging. 2022;115:29-38.
    PubMed     Abstract available


  173. TAN CH, Chew J, Zhang L, Gulyas B, et al
    Differential effects of white matter hyperintensities and regional amyloid deposition on regional cortical thickness.
    Neurobiol Aging. 2022;115:12-19.
    PubMed     Abstract available


  174. LAPOINT MR, Baker SL, Landau SM, Harrison TM, et al
    Rates of beta-amyloid deposition indicate widespread simultaneous accumulation throughout the brain.
    Neurobiol Aging. 2022;115:1-11.
    PubMed     Abstract available


  175. BROWN SSG, Mak E, Clare I, Grigorova M, et al
    Support vector machine learning and diffusion-derived structural networks predict amyloid quantity and cognition in adults with Down's syndrome.
    Neurobiol Aging. 2022;115:112-121.
    PubMed     Abstract available


    June 2022
  176. PALIX C, Felisatti F, Gonneaud J, Kuhn E, et al
    Relationships between diabetes-related vascular risk factors and neurodegeneration biomarkers in healthy aging and Alzheimer's disease.
    Neurobiol Aging. 2022;118:25-33.
    PubMed     Abstract available


  177. TAXIER LR, Philippi SM, Fleischer AW, York JM, et al
    APOE4 homozygote females are resistant to the beneficial effects of 17beta-estradiol on memory and CA1 dendritic spine density in the EFAD mouse model of Alzheimer's disease.
    Neurobiol Aging. 2022;118:13-24.
    PubMed     Abstract available


  178. FOOTE IF, Jacobs BM, Mathlin G, Watson CJ, et al
    The shared genetic architecture of modifiable risk for Alzheimer's disease: a genomic structural equation modelling study.
    Neurobiol Aging. 2022;117:222-235.
    PubMed     Abstract available


  179. KIM J, Jung SH, Choe YS, Kim S, et al
    Ethnic differences in the frequency of beta-amyloid deposition in cognitively normal individuals.
    Neurobiol Aging. 2022;114:27-37.
    PubMed     Abstract available


  180. PALMER JA, Kaufman CS, Vidoni ED, Honea RA, et al
    Cerebrovascular response to exercise interacts with individual genotype and amyloid-beta deposition to influence response inhibition with aging.
    Neurobiol Aging. 2022;114:15-26.
    PubMed     Abstract available


  181. KIM SJ, Woo SY, Kim YJ, Jang H, et al
    Development of prediction models for distinguishable cognitive trajectories in patients with amyloid positive mild cognitive impairment.
    Neurobiol Aging. 2022;114:84-93.
    PubMed     Abstract available


  182. HUTTULA S, Vayrynen H, Helisalmi S, Kytovuori L, et al
    NDUFA1 p.Gly32Arg variant in early-onset dementia.
    Neurobiol Aging. 2022;114:113-116.
    PubMed     Abstract available


    May 2022
  183. KHAIRE AS, Wimberly CE, Semmes EC, Hurst JH, et al
    An integrated genome and phenome-wide association study approach to understanding Alzheimer's disease predisposition.
    Neurobiol Aging. 2022 May 27. pii: S0197-4580(22)00120.
    PubMed     Abstract available


  184. MASSA F, Halbgebauer S, Barba L, Oeckl P, et al
    Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary data.
    Neurobiol Aging. 2022;117:212-221.
    PubMed     Abstract available


  185. MAZZEO S, Polito C, Lassi M, Bagnoli S, et al
    Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline.
    Neurobiol Aging. 2022;117:59-70.
    PubMed     Abstract available


  186. ZHOU XA, Ngiam G, Qian L, Sankorrakul K, et al
    The basal forebrain volume reduction detected by MRI does not necessarily link with the cholinergic neuronal loss in the Alzheimer's disease mouse model.
    Neurobiol Aging. 2022;117:24-32.
    PubMed     Abstract available


  187. DONG R, Denier-Fields DN, Lu Q, Suridjan I, et al
    Principal components from untargeted cerebrospinal fluid metabolomics associated with Alzheimer's disease biomarkers.
    Neurobiol Aging. 2022;117:12-23.
    PubMed     Abstract available


  188. GUISLE I, Canet G, Petry S, Fereydouni-Forouzandeh P, et al
    Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia.
    Neurobiol Aging. 2022;113:118-130.
    PubMed     Abstract available


  189. MORTAMAIS M, Gutierrez LA, Balem M, Bars EL, et al
    Sulcal morphology as cognitive decline predictor in older adults with memory complaints.
    Neurobiol Aging. 2022;113:84-94.
    PubMed     Abstract available


  190. HULSHOF LA, Frajmund LA, van Nuijs D, van der Heijden DCN, et al
    Both male and female APPswe/PSEN1dE9 mice are impaired in spatial memory and cognitive flexibility at 9 months of age.
    Neurobiol Aging. 2022;113:28-38.
    PubMed     Abstract available


  191. QUINTAS-NEVES M, Teylan MA, Morais-Ribeiro R, Almeida F, et al
    Divergent magnetic resonance imaging atrophy patterns in Alzheimer's disease and primary age-related tauopathy.
    Neurobiol Aging. 2022;117:1-11.
    PubMed     Abstract available


    April 2022
  192. XIAO X, Liao X, Zhou Y, Weng L, et al
    Variants in the Niemann-pick type C genes are not associated with Alzheimer's disease: a large case-control study in the Chinese population.
    Neurobiol Aging. 2022;116:49-54.
    PubMed     Abstract available


  193. BABILONI C, Lorenzo I, Lizio R, Lopez S, et al
    Reactivity of posterior cortical electroencephalographic alpha rhythms during eyes opening in cognitively intact older adults and patients with dementia due to Alzheimer's and Lewy body diseases.
    Neurobiol Aging. 2022;115:88-108.
    PubMed     Abstract available


  194. PENG S, Roth AR, Apostolova LG, Saykin AJ, et al
    Cognitively stimulating environments and cognitive reserve: the case of personal social networks.
    Neurobiol Aging. 2022;112:197-203.
    PubMed     Abstract available


  195. MCKAY NS, Dincer A, Mehrotra V, Aschenbrenner AJ, et al
    Beta-amyloid moderates the relationship between cortical thickness and attentional control in middle- and older-aged adults.
    Neurobiol Aging. 2022;112:181-190.
    PubMed     Abstract available


  196. TRAN TT, Speck CL, Gallagher M, Bakker A, et al
    Lateral entorhinal cortex dysfunction in amnestic mild cognitive impairment.
    Neurobiol Aging. 2022;112:151-160.
    PubMed     Abstract available


  197. ARAKAKI X, Hung SM, Rochart R, Fonteh AN, et al
    Alpha desynchronization during Stroop test unmasks cognitively healthy individuals with abnormal CSF Amyloid/Tau.
    Neurobiol Aging. 2022;112:87-101.
    PubMed     Abstract available


  198. JOHNSON AG, Webster JA, Hales CM
    Glial profiling of human tauopathy brain demonstrates enrichment of astrocytic transcripts in tau-related frontotemporal degeneration.
    Neurobiol Aging. 2022;112:55-73.
    PubMed     Abstract available


  199. KARA F, Joers JM, Deelchand DK, Park YW, et al
    (1)H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults.
    Neurobiol Aging. 2022;112:16-26.
    PubMed     Abstract available


    March 2022
  200. LI Y, Macyczko JR, Liu CC, Bu G, et al
    ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease.
    Neurobiol Aging. 2022;115:20-28.
    PubMed     Abstract available


  201. WOODFIELD A, Porter T, Gilani I, Noordin S, et al
    Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF Abeta42 moderates the association between insulin resistance and increased CSF tau levels.
    Neurobiol Aging. 2022;114:38-48.
    PubMed     Abstract available


  202. SCHEIJBELER EP, Schoonhoven DN, Engels MMA, Scheltens P, et al
    Generating diagnostic profiles of cognitive decline and dementia using magnetoencephalography.
    Neurobiol Aging. 2022;111:82-94.
    PubMed     Abstract available


  203. DUGAN AJ, Nelson PT, Katsumata Y, Shade LMP, et al
    Association between WWOX/MAF variants and dementia-related neuropathologic endophenotypes.
    Neurobiol Aging. 2022;111:95-106.
    PubMed     Abstract available


    February 2022
  204. RIPHAGEN JM, Suresh MB, Salat DH
    The canonical pattern of Alzheimer's disease atrophy is linked to white matter hyperintensities in normal controls, differently in normal controls compared to in AD.
    Neurobiol Aging. 2022 Feb 28. pii: S0197-4580(22)00029.
    PubMed     Abstract available


  205. CLEMENT AN, Ribaldi F, Frisoni GB, Garibotto V, et al
    SimulAD: a dynamical model for personalized simulation and disease staging in Alzheimer's disease.
    Neurobiol Aging. 2022;113:73-83.
    PubMed     Abstract available


  206. CATANIA M, Marti A, Rossi G, Fioretti A, et al
    The novel I213S mutation in PSEN1 gene is located in a hotspot codon associated with familial early-onset Alzheimer's disease.
    Neurobiol Aging. 2022;112:191-196.
    PubMed     Abstract available


  207. MALBON AJ, Sordo L, Wilson LA, Gunn-Moore D, et al
    Alzheimer-like pathology in the parietal cortex and hippocampus of aged donkeys.
    Neurobiol Aging. 2022;113:7-14.
    PubMed     Abstract available


  208. NOVY MJ, Newbury SF, Liemisa B, Morales-Corraliza J, et al
    Expression and proteolytic processing of the amyloid precursor protein is unaffected by the expression of the three human apolipoprotein E alleles in the brains of mice.
    Neurobiol Aging. 2022;110:73-76.
    PubMed     Abstract available


    January 2022
  209. LIANG X, Liu C, Liu K, Cong L, et al
    Association and interaction of TOMM40 and PVRL2 with plasma amyloid-beta and Alzheimer's disease among Chinese older adults: a population-based study.
    Neurobiol Aging. 2022 Jan 5. pii: S0197-4580(21)00370.
    PubMed     Abstract available


  210. OLTRA-CUCARELLA J, Sanchez-SanSegundo M, Ferrer-Cascales R
    Predicting Alzheimer's disease with practice effects, APOE genotype and brain metabolism.
    Neurobiol Aging. 2022;112:111-121.
    PubMed     Abstract available


  211. INKSTER AM, Duarte-Guterman P, Albert AY, Barha CK, et al
    Are sex differences in cognitive impairment reflected in epigenetic age acceleration metrics?
    Neurobiol Aging. 2022;109:192-194.
    PubMed     Abstract available


  212. LI T, Pappas C, Le ST, Wang Q, et al
    APOE, TOMM40, and sex interactions on neural network connectivity.
    Neurobiol Aging. 2022;109:158-165.
    PubMed     Abstract available


  213. YOON B, Guo T, Provost K, Korman D, et al
    Abnormal tau in amyloid PET negative individuals.
    Neurobiol Aging. 2022;109:125-134.
    PubMed     Abstract available


    December 2021
  214. TAXIER LR, Philippi SM, York JM, LaDu MJ, et al
    The detrimental effects of APOE4 on risk for Alzheimer's disease may result from altered dendritic spine density, synaptic proteins, and estrogen receptor alpha.
    Neurobiol Aging. 2021;112:74-86.
    PubMed     Abstract available


  215. DAHL MJ, Mather M, Werkle-Bergner M, Kennedy BL, et al
    Locus coeruleus integrity is related to tau burden and memory loss in autosomal-dominant Alzheimer's disease.
    Neurobiol Aging. 2021;112:39-54.
    PubMed     Abstract available


  216. DADAR M, Manera AL, Ducharme S, Collins DL, et al
    White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
    Neurobiol Aging. 2021;111:54-63.
    PubMed     Abstract available


  217. RAMANAN S, Foxe D, El-Omar H, Ahmed RM, et al
    Evidence for a pervasive autobiographical memory impairment in Logopenic Progressive Aphasia.
    Neurobiol Aging. 2021;108:168-178.
    PubMed     Abstract available


  218. VAN DEN BOSCH KA, Verberk IMW, Ebenau JL, van der Lee SJ, et al
    BDNF-Met polymorphism and amyloid-beta in relation to cognitive decline in cognitively normal elderly: the SCIENCe project.
    Neurobiol Aging. 2021;108:146-154.
    PubMed     Abstract available


  219. FRANZ CE, Hatton SN, Elman JA, Warren T, et al
    Lifestyle and the aging brain: interactive effects of modifiable lifestyle behaviors and cognitive ability in men from midlife to old age.
    Neurobiol Aging. 2021;108:80-89.
    PubMed     Abstract available


  220. SAMIMI N, Sharma G, Kimura T, Matsubara T, et al
    Distinct phosphorylation profiles of tau in brains of patients with different tauopathies.
    Neurobiol Aging. 2021;108:72-79.
    PubMed     Abstract available


  221. HU B, Geng C, Guo F, Liu Y, et al
    GABAA receptor agonist muscimol rescues inhibitory microcircuit defects in the olfactory bulb and improves olfactory function in APP/PS1 transgenic mice.
    Neurobiol Aging. 2021;108:47-57.
    PubMed     Abstract available


    November 2021
  222. PINI L, Pizzini FB, Boscolo-Galazzo I, Ferrari C, et al
    Brain network modulation in Alzheimer's and frontotemporal dementia with transcranial electrical stimulation.
    Neurobiol Aging. 2021;111:24-34.
    PubMed     Abstract available


  223. MECCA AP, Chen MK, O'Dell RS, Naganawa M, et al
    Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease.
    Neurobiol Aging. 2021;111:44-53.
    PubMed     Abstract available


  224. FRANCIOTTI R, Moretti DV, Benussi A, Ferri L, et al
    Cortical network modularity changes along the course of frontotemporal and Alzheimer's dementing diseases.
    Neurobiol Aging. 2021;110:37-46.
    PubMed     Abstract available


  225. EKBLAD LL, Visser PJ, Tijms BM
    Proteomic correlates of cortical thickness in cognitively normal individuals with normal and abnormal cerebrospinal fluid beta-amyloid1-42.
    Neurobiol Aging. 2021;107:42-52.
    PubMed     Abstract available


  226. SHAROAR MG, Zhou J, Benoit M, He W, et al
    Dynactin 6 deficiency enhances aging-associated dystrophic neurite formation in mouse brains.
    Neurobiol Aging. 2021;107:21-29.
    PubMed     Abstract available


    October 2021
  227. JONIN PY, Duche Q, Bannier E, Corouge I, et al
    Building memories on prior knowledge: behavioral and fMRI evidence of impairment in early Alzheimer's disease.
    Neurobiol Aging. 2021;110:1-12.
    PubMed     Abstract available


  228. KO K, Yi D, Byun MS, Lee JH, et al
    Cognitive reserve proxies, Alzheimer pathologies, and cognition.
    Neurobiol Aging. 2021;110:88-95.
    PubMed     Abstract available


  229. ZHANG H, Wang H, Gao F, Yang J, et al
    TSPO deficiency accelerates amyloid pathology and neuroinflammation by impairing microglial phagocytosis.
    Neurobiol Aging. 2021;106:292-303.
    PubMed     Abstract available


  230. KOINUMA S, Shimozawa N, Yasutomi Y, Kimura N, et al
    Aging induces abnormal accumulation of Abeta in extracellular vesicle and/or intraluminal membrane vesicle-rich fractions in nonhuman primate brain.
    Neurobiol Aging. 2021;106:268-281.
    PubMed     Abstract available


  231. VAN DER THIEL MM, Freeze WM, Verheggen ICM, Wong SM, et al
    Associations of increased interstitial fluid with vascular and neurodegenerative abnormalities in a memory clinic sample.
    Neurobiol Aging. 2021;106:257-267.
    PubMed     Abstract available


  232. LEE YG, Park M, Jeong SH, Kang SW, et al
    Effects of baseline serum uric acid and apolipoprotein E4 on longitudinal cognition and cerebral metabolism.
    Neurobiol Aging. 2021;106:223-231.
    PubMed     Abstract available


  233. CULLELL N, Carcel-Marquez J, Gallego-Fabrega C, Muino E, et al
    Sleep/wake cycle alterations as a cause of neurodegenerative diseases: A Mendelian randomization study.
    Neurobiol Aging. 2021;106:320.
    PubMed     Abstract available


  234. LORD J, Zettergren A, Ashton NJ, Karikari TK, et al
    A genome-wide association study of plasma phosphorylated tau181.
    Neurobiol Aging. 2021;106:304.
    PubMed     Abstract available


    September 2021
  235. HONE-BLANCHET A, Bohsali A, Krishnamurthy LC, Shahid S, et al
    Relationships between frontal metabolites and Alzheimer's disease biomarkers in cognitively normal older adults.
    Neurobiol Aging. 2021;109:22-30.
    PubMed     Abstract available


  236. KULMINSKI AM, Philipp I, Shu L, Culminskaya I, et al
    Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk.
    Neurobiol Aging. 2021 Sep 15. pii: S0197-4580(21)00290.
    PubMed     Abstract available


  237. KOENIG LN, LaMontagne P, Glasser MF, Bateman R, et al
    Regional age-related atrophy after screening for preclinical alzheimer disease.
    Neurobiol Aging. 2021;109:43-51.
    PubMed     Abstract available


  238. CHARISSE D, Erus G, Pomponio R, Gorges M, et al
    Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease.
    Neurobiol Aging. 2021;109:31-42.
    PubMed     Abstract available


  239. BONOMI CG, De Lucia V, Mascolo AP, Assogna M, et al
    Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias.
    Neurobiol Aging. 2021;105:333-339.
    PubMed     Abstract available


  240. OLAJIDE OJ, Chapman CA
    Amyloid-beta (1-42) peptide induces rapid NMDA receptor-dependent alterations at glutamatergic synapses in the entorhinal cortex.
    Neurobiol Aging. 2021;105:296-309.
    PubMed     Abstract available


  241. ENNIS GE, Kohli A, Jonaitis EM, Betthauser TJ, et al
    The relationship of glucose-stimulated insulin secretion to cerebral glucose metabolism and cognition in healthy middle-aged and older adults.
    Neurobiol Aging. 2021;105:174-185.
    PubMed     Abstract available


  242. QUINTANA DD, Anantula Y, Garcia JA, Engler-Chiurazzi EB, et al
    Microvascular degeneration occurs before plaque onset and progresses with age in 3xTg AD mice.
    Neurobiol Aging. 2021;105:115-128.
    PubMed     Abstract available


  243. CARLYLE BC, Kandigian SE, Kreuzer J, Das S, et al
    Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics.
    Neurobiol Aging. 2021;105:99-114.
    PubMed     Abstract available


  244. SIBLE IJ, Yew B, Dutt S, Bangen KJ, et al
    Visit-to-visit blood pressure variability and regional cerebral perfusion decline in older adults.
    Neurobiol Aging. 2021;105:57-63.
    PubMed     Abstract available


  245. KNIGHT SP, Laird E, Williamson W, O'Connor J, et al
    Obesity is associated with reduced cerebral blood flow - modified by physical activity.
    Neurobiol Aging. 2021;105:35-47.
    PubMed     Abstract available


    August 2021
  246. WHITWELL JL, Tosakulwong N, Weigand SD, Graff-Radford J, et al
    Relationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease.
    Neurobiol Aging. 2021;108:90-98.
    PubMed     Abstract available


  247. ZHANG Z, Wang M, Liu X
    C-reactive protein and risk of Alzheimer's disease.
    Neurobiol Aging. 2021 Aug 21. pii: S0197-4580(21)00264.
    PubMed     Abstract available


  248. PALIWAL D, McInerney TW, Pa J, Swerdlow RH, et al
    Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease.
    Neurobiol Aging. 2021 Aug 18. pii: S0197-4580(21)00259.
    PubMed     Abstract available


  249. SHEPHERD A, Lim JKH, Wong VHY, Zeleznikow-Johnston AM, et al
    Progressive impairments in executive function in the APP/PS1 model of Alzheimer's disease as measured by translatable touchscreen testing.
    Neurobiol Aging. 2021;108:58-71.
    PubMed     Abstract available


  250. WILLEMSE EAJ, Sieben A, Somers C, Vermeiren Y, et al
    Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia.
    Neurobiol Aging. 2021;108:99-109.
    PubMed     Abstract available


  251. BELFIORE ACR, Oddo S
    Retraction notice to "Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease" [Neurobiology of Aging Volume 68, August 2018, Page 59-67].
    Neurobiol Aging. 2021;104:139.
    PubMed    


  252. SHAFER AT, Beason-Held L, An Y, Williams OA, et al
    Default mode network connectivity and cognition in the aging brain: the effects of age, sex, and APOE genotype.
    Neurobiol Aging. 2021;104:10-23.
    PubMed     Abstract available


    July 2021
  253. FLEMING V, Piro-Gambetti B, Patrick A, Zammit M, et al
    Physical activity and cognitive and imaging biomarkers of Alzheimer's disease in down syndrome.
    Neurobiol Aging. 2021;107:118-127.
    PubMed     Abstract available


  254. TATARYN NM, Singh V, Dyke JP, Berk-Rauch HE, et al
    Vascular endothelial growth factor associated dissimilar cerebrovascular phenotypes in two different mouse models of Alzheimer's Disease.
    Neurobiol Aging. 2021;107:96-108.
    PubMed     Abstract available


  255. IONESCU-TUCKER A, Cotman CW
    Emerging roles of oxidative stress in brain aging and Alzheimer's disease.
    Neurobiol Aging. 2021;107:86-95.
    PubMed     Abstract available


  256. LIM B, Grontvedt GR, Bathala P, Kale SS, et al
    CSF neurofilament light may predict progression from amnestic mild cognitive impairment to Alzheimer's disease dementia.
    Neurobiol Aging. 2021;107:78-85.
    PubMed     Abstract available


  257. MIN S, Li Z, Shieh A, Giase G, et al
    Absence of coding somatic single nucleotide variants within well-known candidate genes in late-onset sporadic Alzheimer's Disease based on the analysis of multi-omics data.
    Neurobiol Aging. 2021 Jul 21. pii: S0197-4580(21)00236.
    PubMed     Abstract available


  258. LEMERCIER P, Vergallo A, Lista S, Zetterberg H, et al
    Association of plasma Abeta40/Abeta42 ratio and brain Abeta accumulation: testing a whole-brain PLS-VIP approach in individuals at risk of Alzheimer's disease.
    Neurobiol Aging. 2021;107:57-69.
    PubMed     Abstract available


  259. NAUDE PJW, Ramakers IHGB, van der Flier WM, Jiskoot LC, et al
    Serum and cerebrospinal fluid Neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer's disease dementia.
    Neurobiol Aging. 2021;107:1-10.
    PubMed     Abstract available


  260. VAN DER LINDEN RJ, Reus LM, De Witte W, Tijms BM, et al
    Genetic overlap between Alzheimer's disease and blood lipid levels.
    Neurobiol Aging. 2021 Jul 3. pii: S0197-4580(21)00213.
    PubMed     Abstract available


  261. CEYZERIAT K, Zilli T, Fall AB, Millet P, et al
    Treatment by low-dose brain radiation therapy improves memory performances without changes of the amyloid load in the TgF344-AD rat model.
    Neurobiol Aging. 2021;103:117-127.
    PubMed     Abstract available


  262. XU W, Tan CC, Cao XP, Tan L, et al
    Neuroinflammation modulates the association of PGRN with cerebral amyloid-beta burden.
    Neurobiol Aging. 2021;103:52-59.
    PubMed     Abstract available


    June 2021
  263. RUSSO ML, Molina-Campos E, Ybarra N, Rogalsky AE, et al
    Variability in sub-threshold signaling linked to Alzheimer's disease emerges with age and amyloid plaque deposition in mouse ventral CA1 pyramidal neurons.
    Neurobiol Aging. 2021;106:207-222.
    PubMed     Abstract available


  264. ZADEY S, Buss SS, McDonald K, Press DZ, et al
    Higher motor cortical excitability linked to greater cognitive dysfunction in Alzheimer's disease: results from two independent cohorts.
    Neurobiol Aging. 2021;108:24-33.
    PubMed     Abstract available


  265. PFEIL J, Hoenig MC, Doering E, van Eimeren T, et al
    Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer's disease.
    Neurobiol Aging. 2021;106:119-129.
    PubMed     Abstract available


  266. JUNG JH, Jeon S, Baik K, Lee YH, et al
    Apolipoprotein E4, amyloid, and cognition in Alzheimer's and Lewy body disease.
    Neurobiol Aging. 2021;106:45-54.
    PubMed     Abstract available


  267. SANGHA O, Ma D, Popuri K, Stocks J, et al
    Structural volume and cortical thickness differences between males and females in cognitively normal, cognitively impaired and Alzheimer's dementia population.
    Neurobiol Aging. 2021;106:1-11.
    PubMed     Abstract available


  268. BANKS SJ, Andrews MJ, Digma L, Madsen J, et al
    Sex differences in Alzheimer's disease: do differences in tau explain the verbal memory gap?
    Neurobiol Aging. 2021;107:70-77.
    PubMed     Abstract available


  269. BUTT OH, Long JM, Henson RL, Herries E, et al
    Cognitively normal APOE epsilon4 carriers have specific elevation of CSF SNAP-25.
    Neurobiol Aging. 2021;102:64-72.
    PubMed     Abstract available


    May 2021
  270. XIAO X, Yuan Z, Guo L, Liao X, et al
    The role of frontotemporal dementia associated genes in patients with Alzheimer's disease.
    Neurobiol Aging. 2021 May 30. pii: S0197-4580(21)00179.
    PubMed     Abstract available


  271. TUBI MA, Kothapalli D, Hapenney M, Feingold FW, et al
    Regional relationships between CSF VEGF levels and Alzheimer's disease brain biomarkers and cognition.
    Neurobiol Aging. 2021;105:241-251.
    PubMed     Abstract available


  272. GAUBERT S, Houot M, Raimondo F, Ansart M, et al
    A machine learning approach to screen for preclinical Alzheimer's disease.
    Neurobiol Aging. 2021;105:205-216.
    PubMed     Abstract available


  273. BOSSAERTS L, Hens E, Hanseeuw B, Vandenberghe R, et al
    Premature termination codon mutations in ABCA7 contribute to Alzheimer's disease risk in Belgian patients.
    Neurobiol Aging. 2021 May 2. pii: S0197-4580(21)00146.
    PubMed     Abstract available


  274. BEHESHTI I, Nugent S, Potvin O, Duchesne S, et al
    Disappearing metabolic youthfulness in the cognitively impaired female brain.
    Neurobiol Aging. 2021;101:224-229.
    PubMed     Abstract available


  275. KRONENBERG G, Gertz K, Schoner J, Bertram L, et al
    BDNF serum concentrations in 2053 participants of the Berlin Aging Study II.
    Neurobiol Aging. 2021;101:221-223.
    PubMed     Abstract available


  276. BELLOY ME, Eger SJ, Le Guen Y, Napolioni V, et al
    KL *VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE *4 carriers.
    Neurobiol Aging. 2021;101:123-129.
    PubMed     Abstract available


  277. ZUO Z, Qi F, Xing Z, Yuan L, et al
    Bacille Calmette-Guerin attenuates vascular amyloid pathology and maximizes synaptic preservation in APP/PS1 mice following active amyloid-beta immunotherapy.
    Neurobiol Aging. 2021;101:94-108.
    PubMed     Abstract available


  278. SMITH GS, Kuwabara H, Nandi A, Gould NF, et al
    Molecular imaging of beta-amyloid deposition in late-life depression.
    Neurobiol Aging. 2021;101:85-93.
    PubMed     Abstract available


  279. ASTROSKI JW, Akporyoe LK, Androphy EJ, Custer SK, et al
    Mutations in the COPI coatomer subunit alpha-COP induce release of Abeta-42 and amyloid precursor protein intracellular domain and increase tau oligomerization and release.
    Neurobiol Aging. 2021;101:57-69.
    PubMed     Abstract available


    April 2021
  280. TSAKIRI EN, Gumeni S, Manola MS, Trougakos IP, et al
    Amyloid toxicity in a Drosophila Alzheimer's model is ameliorated by autophagy activation.
    Neurobiol Aging. 2021;105:137-147.
    PubMed     Abstract available


  281. EDWARDS L, La Joie R, Iaccarino L, Strom A, et al
    Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females.
    Neurobiol Aging. 2021;105:86-98.
    PubMed     Abstract available


  282. RABIPOUR S, Rajagopal S, Pasvanis S, Rajah MN, et al
    Generalization of memory-related brain function in asymptomatic older women with a family history of late onset Alzheimer's Disease: Results from the PREVENT-AD Cohort.
    Neurobiol Aging. 2021;104:42-56.
    PubMed     Abstract available


  283. OBERRAUCH S, Metha JA, Brian ML, Barnes SA, et al
    Reward motivation and cognitive flexibility in tau null-mutation mice.
    Neurobiol Aging. 2021;100:106-117.
    PubMed     Abstract available


  284. OUK M, Wu CY, Rabin JS, Edwards JD, et al
    Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers.
    Neurobiol Aging. 2021;100:22-31.
    PubMed     Abstract available


    March 2021
  285. HOOGMARTENS J, Hens E, Engelborghs S, De Deyn PP, et al
    Investigation of the role of matrix metalloproteinases in the genetic etiology of Alzheimer's disease.
    Neurobiol Aging. 2021 Mar 28. pii: S0197-4580(21)00102.
    PubMed     Abstract available


  286. CASH MK, Rockwood K, Fisk JD, Darvesh S, et al
    Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro.
    Neurobiol Aging. 2021;103:31-41.
    PubMed     Abstract available


  287. HU K, Li P, Gao L
    Sleep, rest-activity rhythms and aging: a complex web in Alzheimer's disease?
    Neurobiol Aging. 2021 Mar 2. pii: S0197-4580(21)00072.
    PubMed    


  288. MESQUITA LLR, Mesquita LP, Wadt D, Bruhn FRP, et al
    Heterogenous deposition of beta-amyloid in the brain of aged dogs.
    Neurobiol Aging. 2021;99:44-52.
    PubMed     Abstract available


    February 2021
  289. NUEBLING GS, Prix C, Brendel M, Beyer L, et al
    Low-degree trisomy 21 mosaicism promotes early-onset Alzheimer disease.
    Neurobiol Aging. 2021 Feb 28. pii: S0197-4580(21)00076.
    PubMed     Abstract available


  290. CACCIOTTOLO M, Morgan TE, Finch CE
    Age, sex, and cerebral microbleeds in EFAD Alzheimer disease mice.
    Neurobiol Aging. 2021;103:42-51.
    PubMed     Abstract available


  291. RAJABLI F, Feliciano-Astacio BE, Cukier HN, Wang L, et al
    Linkage of Alzheimer disease families with Puerto Rican ancestry identifies a chromosome 9 locus.
    Neurobiol Aging. 2021 Feb 28. pii: S0197-4580(21)00074.
    PubMed     Abstract available


  292. BETTCHER BM, Olson KE, Carlson NE, McConnell BV, et al
    Astrogliosis and episodic memory in late life: higher GFAP is related to worse memory and white matter microstructure in healthy aging and Alzheimer's disease.
    Neurobiol Aging. 2021;103:68-77.
    PubMed     Abstract available


  293. KARA F, Belloy ME, Voncken R, Sarwari Z, et al
    Long-term ovarian hormone deprivation alters functional connectivity, brain neurochemical profile and white matter integrity in the Tg2576 amyloid mouse model of Alzheimer's disease.
    Neurobiol Aging. 2021;102:139-150.
    PubMed     Abstract available


  294. RUBINSKI A, Tosun D, Franzmeier N, Neitzel J, et al
    Lower cerebral perfusion is associated with tau-PET in the entorhinal cortex across the Alzheimer's continuum.
    Neurobiol Aging. 2021;102:111-118.
    PubMed     Abstract available


  295. VAN HOOREN RWE, Verhey FRJ, Ramakers IHGB, Jansen WJ, et al
    Elevated norepinephrine metabolism is linked to cortical thickness in the context of Alzheimer's disease pathology.
    Neurobiol Aging. 2021;102:17-22.
    PubMed     Abstract available


  296. GIOVAGNONI C, Ali M, Eijssen LMT, Maes R, et al
    Altered sphingolipid function in Alzheimer's disease; a gene regulatory network approach.
    Neurobiol Aging. 2021;102:178-187.
    PubMed     Abstract available


  297. O'CONNOR A, Abel E, Fraser MR, Ryan NS, et al
    A novel presenilin 1 duplication mutation (Ile168dup) causing Alzheimer's disease associated with myoclonus, seizures and pyramidal features.
    Neurobiol Aging. 2021 Feb 5. pii: S0197-4580(21)00046.
    PubMed     Abstract available


  298. ALLISON SL, Jonaitis EM, Koscik RL, Hermann BP, et al
    Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age.
    Neurobiol Aging. 2021;102:151-160.
    PubMed     Abstract available


  299. CHUNG SJ, Lee S, Yoo HS, Baik K, et al
    Different patterns of beta-amyloid deposition in patients with Alzheimer's disease according to the presence of mild parkinsonism.
    Neurobiol Aging. 2021;101:199-206.
    PubMed     Abstract available


  300. KIM BH, Nho K, Lee JM
    Genome-wide association study identifies susceptibility loci of brain atrophy to NFIA and ST18 in Alzheimer's disease.
    Neurobiol Aging. 2021 Feb 3. pii: S0197-4580(21)00028.
    PubMed     Abstract available


  301. WISSE LEM, Ungrady MB, Ittyerah R, Lim SA, et al
    Cross-sectional and longitudinal medial temporal lobe subregional atrophy patterns in semantic variant primary progressive aphasia.
    Neurobiol Aging. 2021;98:231-241.
    PubMed     Abstract available


  302. GUO C, Zhang Y, Nie Q, Cao D, et al
    SQSTM1/ p62 oligomerization contributes to Abeta-induced inhibition of Nrf2 signaling.
    Neurobiol Aging. 2021;98:10-20.
    PubMed     Abstract available


  303. MUSCAT SM, Deems NP, D'Angelo H, Kitt MM, et al
    Postoperative cognitive dysfunction is made persistent with morphine treatment in aged rats.
    Neurobiol Aging. 2021;98:214-224.
    PubMed     Abstract available


  304. YEUNG LK, Hale C, Rizvi B, Igwe K, et al
    Anterolateral entorhinal cortex volume is associated with memory retention in clinically unimpaired older adults.
    Neurobiol Aging. 2021;98:134-145.
    PubMed     Abstract available


  305. LOW A, Su L, Stefaniak JD, Mak E, et al
    Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study.
    Neurobiol Aging. 2021;98:124-133.
    PubMed     Abstract available


  306. MEEKER KL, Ances BM, Gordon BA, Rudolph CW, et al
    Cerebrospinal fluid Abeta42 moderates the relationship between brain functional network dynamics and cognitive intraindividual variability.
    Neurobiol Aging. 2021;98:116-123.
    PubMed     Abstract available


    January 2021
  307. PARK JE, Lee YJ, Byun MS, Yi D, et al
    Differential associations of age and Alzheimer's disease with sleep and rest-activity rhythms across the adult lifespan.
    Neurobiol Aging. 2021;101:141-149.
    PubMed     Abstract available


  308. MONDRAGON JD, Maurits NM, De Deyn PP
    Functional connectivity differences in Alzheimer's disease and amnestic mild cognitive impairment associated with AT(N) classification and anosognosia.
    Neurobiol Aging. 2021;101:22-39.
    PubMed     Abstract available


  309. CHENG Z, Shang Y, Xu X, Dong Z, et al
    Presenilin 1 mutation likely contributes to U1 small nuclear RNA dysregulation and Alzheimer's disease-like symptoms.
    Neurobiol Aging. 2021;100:1-10.
    PubMed     Abstract available


  310. DECKER Y, Nemeth E, Schomburg R, Chemla A, et al
    Decreased pH in the aging brain and Alzheimer's disease.
    Neurobiol Aging. 2021;101:40-49.
    PubMed     Abstract available


  311. PALTA P, Rippon B, Tahmi M, Sherwood G, et al
    Metabolic syndrome and its components in relation to in vivo brain amyloid and neurodegeneration in late middle age.
    Neurobiol Aging. 2021;97:89-96.
    PubMed     Abstract available


    December 2020
  312. MIYAGAWA T, Przybelski SA, Maltais D, Min HK, et al
    The value of multimodal imaging with (123)I-FP-CIT SPECT in differential diagnosis of dementia with Lewy bodies and Alzheimer's disease dementia.
    Neurobiol Aging. 2020;99:11-18.
    PubMed     Abstract available


  313. BAE J, Stocks J, Heywood A, Jung Y, et al
    Transfer learning for predicting conversion from mild cognitive impairment to dementia of Alzheimer's type based on a three-dimensional convolutional neural network.
    Neurobiol Aging. 2020;99:53-64.
    PubMed     Abstract available


  314. MARCA-YSABEL MV, Rajabli F, Cornejo-Olivas M, Whitehead PG, et al
    Dissecting the role of Amerindian genetic ancestry and the ApoE epsilon4 allele on Alzheimer disease in an admixed Peruvian population.
    Neurobiol Aging. 2020 Dec 10. pii: S0197-4580(20)30312.
    PubMed     Abstract available


  315. WENG FL, He L
    Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease.
    Neurobiol Aging. 2020;99:79-85.
    PubMed     Abstract available


    November 2020
  316. YANG W, Zhou X, Ryazanov AG, Ma T, et al
    Suppression of the kinase for elongation factor 2 alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease.
    Neurobiol Aging. 2020;98:225-230.
    PubMed     Abstract available


  317. LAWINGCO T, Chaudhury S, Brookes KJ, Guetta-Baranes T, et al
    Genetic variants in glutamate-, Abeta-, and tau-related pathways determine polygenic risk for Alzheimer's disease.
    Neurobiol Aging. 2020 Nov 12. pii: S0197-4580(20)30391.
    PubMed     Abstract available


  318. ZHUANG Z, Gao M, Yang R, Liu Z, et al
    Causal relationships between gut metabolites and Alzheimer's disease: a bidirectional Mendelian randomization study.
    Neurobiol Aging. 2020 Nov 12. pii: S0197-4580(20)30334.
    PubMed     Abstract available


  319. FOO H, Thalamuthu A, Jiang J, Koch F, et al
    Associations between Alzheimer's disease polygenic risk scores and hippocampal subfield volumes in 17,161 UK Biobank participants.
    Neurobiol Aging. 2020;98:108-115.
    PubMed     Abstract available


  320. MANZALI SB, Ravona-Springer R, Alkelai A, Yu E, et al
    Association of the CD2AP locus with cognitive functioning among middle-aged individuals with a family history of Alzheimer's disease.
    Neurobiol Aging. 2020;101:50-56.
    PubMed     Abstract available


  321. MURRAY AN, Chandler HL, Lancaster TM
    Multimodal hippocampal and amygdala subfield volumetry in polygenic risk for Alzheimer's disease.
    Neurobiol Aging. 2020;98:33-41.
    PubMed     Abstract available


    October 2020
  322. SALAZAR AM, Leisgang AM, Ortiz AA, Murtishaw AS, et al
    Alterations of GABA B receptors in the APP/PS1 mouse model of Alzheimer's disease.
    Neurobiol Aging. 2020;97:129-143.
    PubMed     Abstract available


  323. GAUBA E, Sui S, Tian J, Driskill C, et al
    Modulation of OSCP mitigates mitochondrial and synaptic deficits in a mouse model of Alzheimer's pathology.
    Neurobiol Aging. 2020;98:63-77.
    PubMed     Abstract available


  324. HENDRIX RD, Ou Y, Davis JE, Odle AK, et al
    Alzheimer amyloid-beta- peptide disrupts membrane localization of glucose transporter 1 in astrocytes: implications for glucose levels in brain and blood.
    Neurobiol Aging. 2020;97:73-88.
    PubMed     Abstract available


  325. KWOK MK, Schooling CM
    Herpes simplex virus and Alzheimer's disease: a Mendelian randomization study.
    Neurobiol Aging. 2020 Oct 9. pii: S0197-4580(20)30309.
    PubMed     Abstract available


  326. PAES D, Lardenoije R, Carollo RM, Roubroeks JAY, et al
    Increased isoform-specific phosphodiesterase 4D expression is associated with pathology and cognitive impairment in Alzheimer's disease.
    Neurobiol Aging. 2020;97:56-64.
    PubMed     Abstract available


  327. LIU D, Wang Y, Jing H, Meng Q, et al
    Mendelian randomization integrating GWAS and mQTL data identified novel pleiotropic DNA methylation loci for neuropathology of Alzheimer's disease.
    Neurobiol Aging. 2020;97:18-27.
    PubMed     Abstract available


    September 2020
  328. FULTON-HOWARD B, Goate AM, Adelson RP, Koppel J, et al
    Greater effect of polygenic risk score for Alzheimer's disease among younger cases who are apolipoprotein E-epsilon4 carriers.
    Neurobiol Aging. 2020 Sep 30. pii: S0197-4580(20)30291.
    PubMed     Abstract available


  329. WALSH P, Sudre CH, Fiford CM, Ryan NS, et al
    The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's disease.
    Neurobiol Aging. 2020;97:10-17.
    PubMed     Abstract available


  330. HOOGMARTENS J, Hens E, Engelborghs S, Vandenberghe R, et al
    Contribution of homozygous and compound heterozygous missense mutations in VWA2 to Alzheimer's disease.
    Neurobiol Aging. 2020 Sep 12. pii: S0197-4580(20)30286.
    PubMed     Abstract available


  331. GUO B, Huang Y, Gao Q, Zhou Q, et al
    Stabilization of microtubules improves cognitive functions and axonal transport of mitochondria in Alzheimer's disease model mice.
    Neurobiol Aging. 2020;96:223-232.
    PubMed     Abstract available


  332. MASSA F, Grisanti S, Brugnolo A, Doglione E, et al
    The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease.
    Neurobiol Aging. 2020;96:117-127.
    PubMed     Abstract available


  333. CACERES A, Gonzalez JR
    Female-specific risk of Alzheimer's disease is associated with tau phosphorylation processes: A transcriptome-wide interaction analysis.
    Neurobiol Aging. 2020;96:104-108.
    PubMed     Abstract available


  334. FRANCIOTTI R, Pilotto A, Moretti DV, Falasca NW, et al
    Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study.
    Neurobiol Aging. 2020;93:55-60.
    PubMed     Abstract available


  335. CODY KA, Piro-Gambetti B, Zammit MD, Christian BT, et al
    Association of sleep with cognition and beta amyloid accumulation in adults with Down syndrome.
    Neurobiol Aging. 2020;93:44-51.
    PubMed     Abstract available


  336. RAMOS-CAMPOY O, Antonell A, Falgas N, Balasa M, et al
    Screening of dementia genes by whole-exome sequencing in Spanish patients with early-onset dementia: likely pathogenic, uncertain significance and risk variants.
    Neurobiol Aging. 2020;93:e1-e9.
    PubMed     Abstract available


  337. RABIN JS, Shirzadi Z, Swardfager W, MacIntosh BJ, et al
    Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults.
    Neurobiol Aging. 2020;93:124-130.
    PubMed     Abstract available


    August 2020
  338. MILLAR PR, Ances BM, Gordon BA, Benzinger TLS, et al
    Evaluating resting-state BOLD variability in relation to biomarkers of preclinical Alzheimer's disease.
    Neurobiol Aging. 2020;96:233-245.
    PubMed     Abstract available


    July 2020
  339. DOUNAVI ME, Mak E, Wells K, Ritchie K, et al
    Volumetric alterations in the hippocampal subfields of subjects at increased risk of dementia.
    Neurobiol Aging. 2020;91:36-44.
    PubMed     Abstract available


  340. ZHOU F, Yan XD, Wang C, He YX, et al
    Suvorexant ameliorates cognitive impairments and pathology in APP/PS1 transgenic mice.
    Neurobiol Aging. 2020;91:66-75.
    PubMed     Abstract available


    June 2020
  341. CHANDRA A, Farrell C, Wilson H, Dervenoulas G, et al
    Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrum.
    Neurobiol Aging. 2020;97:1-9.
    PubMed     Abstract available


  342. BAUER CE, Brown CA, Gold BT
    Education does not protect cognitive function from brain pathology in the ADNI 2 cohort.
    Neurobiol Aging. 2020;90:147-149.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.